Xylem Inc
XYL: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$383.00 | Kdyfbs | Dlwkfpnw |
Xylem: Reiterating Narrow Moat Rating and $97 Fair Value Estimate After Evoqua Acquisition
After reviewing our assumptions for Xylem following the completion of its acquisition of Evoqua, we reiterate our narrow moat rating and $97 fair value estimate but downgrade our moat trend rating to stable from positive. We see the name as fairly valued, with the stock currently trading in 3-star territory.